News
-
-
PRESS RELEASE
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
Mainz Biomed to present eAArly DETECT study results at Digestive Disease Week 2024 in Washington, D.C. Revealing high sensitivity and specificity in colorectal cancer screening -
-
PRESS RELEASE
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test
Mainz Biomed reports positive topline results from pooled study evaluating novel mRNA biomarkers and proprietary AI algorithm for integration into pivotal FDA PMA clinical trial for next-gen CRC test -
-
-
-
PRESS RELEASE
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Mainz Biomed to host HALLO DOC! event focusing on Colorectal Cancer treatment innovations, with expert insights, patient perspective, interactive sessions, innovative research, and networking opportunities. Date: March 20, 2024, Location: Berlin, Germany -
-
PRESS RELEASE
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
Mainz Biomed to host webinar on Early Detection of Colorectal Cancer - Explore new laboratory diagnostic options on March 20, 2024. Event targets pharmacists, physicians, and healthcare professionals
